Mindray Medical International ( MR) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 1.8%. By the end of trading, Mindray Medical International rose 21 cents (0.8%) to $27.30 on light volume. Throughout the day, 351,253 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 611,500 shares. The stock ranged in a price between $26.62-$27.57 after having opened the day at $26.81 as compared to the previous trading day's close of $27.09. Other companies within the Health Care sector that increased today were: Momenta Pharmaceuticals Inc ( MNTA), up 20.9%, Cormedix Inc ( CRMD), up 16.7%, Zalicus Inc ( ZLCS), up 15.8%, and Complete Genomics Inc ( GNOM), up 14%. Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., develops, manufactures, and markets medical devices worldwide. Mindray Medical International has a market cap of $2.9 billion and is part of the health services industry. The company has a P/E ratio of 19.6, above the average health services industry P/E ratio of 18.9 and above the S&P 500 P/E ratio of 17.7. Shares are down 0.3% year to date as of the close of trading on Friday. TheStreet Ratings rates Mindray Medical International as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and disappointing return on equity.
- You can view the full Mindray Medical International Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.